# FDA 483 - TTY Biopharm Company Limited Lioudu Factory - August 30, 2022

Source: https://www.globalkeysolutions.net/records/483/tty-biopharm-company-limited-lioudu-factory/ad932e7b-0c38-45da-903b-45ec8ac0dc27

> FDA 483 for TTY Biopharm Company Limited Lioudu Factory on August 30, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: TTY Biopharm Company Limited Lioudu Factory
- Inspection Date: 2022-08-30
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I
- Summary: TTY Biopharm Company Limited Lioudu Factory, an injectable drug manufacturer in Keelung City, Taiwan, was cited for four observations during an FDA inspection. Key issues include inadequate retention of reserve drug product samples, unrecorded deviations from test procedures, insufficient CGMP training for employees, and a lack of hot water in washing and toilet facilities. These observations indicate deficiencies in quality control, documentation, personnel training, and facility maintenance.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/kham-phommachanh/cc7e728e-d2a1-469d-be3a-4f5fdd43b2dc)

Company: https://www.globalkeysolutions.net/companies/tty-biopharm-company-limited-lioudu-factory/21d00be7-29b5-41a5-b06f-f273e5d1b6f3

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1